1. Home
  2. WEAV vs DNA Comparison

WEAV vs DNA Comparison

Compare WEAV & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

HOLD

Current Price

$5.52

Market Cap

487.7M

Sector

Technology

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$7.79

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEAV
DNA
Founded
2011
2008
Country
United States
United States
Employees
N/A
485
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
487.7M
455.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
WEAV
DNA
Price
$5.52
$7.79
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$11.00
$8.50
AVG Volume (30 Days)
911.3K
1.2M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
7.50
N/A
EPS
N/A
N/A
Revenue
$239,024,000.00
N/A
Revenue This Year
$17.20
N/A
Revenue Next Year
$13.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$4.24
$5.37
52 Week High
$9.10
$17.58

Technical Indicators

Market Signals
Indicator
WEAV
DNA
Relative Strength Index (RSI) 47.38 43.08
Support Level $4.93 $7.59
Resistance Level $5.56 $9.58
Average True Range (ATR) 0.29 0.76
MACD -0.06 -0.14
Stochastic Oscillator 22.31 5.86

Price Performance

Historical Comparison
WEAV
DNA

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: